Heilmann H P
Hermann-Holthusen-Institut für Strahlentherapie, AK St. Georg, Hamburg.
Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir. 1990:95-8.
Postoperative radiotherapy as a routine procedure has failed to show any benefit in prospective randomized studies. Local failure was diminished, but survival rates remained unchanged, probably because of radiation complications. By improvement of radiation techniques, however, reduction of single doses and total dose and focusing postoperative irradiation of lung cancer to high risk cases (N2, T4) survival rates with postoperative irradiation are about 20% after 5 years. The results of 191 treated patients are demonstrated.
在前瞻性随机研究中,将术后放疗作为常规程序未能显示出任何益处。局部失败率有所降低,但生存率并未改变,这可能是由于放疗并发症所致。然而,通过改进放疗技术,减少单次剂量和总剂量,并将肺癌术后放疗集中于高危病例(N2、T4),术后放疗的5年生存率约为20%。文中展示了191例接受治疗患者的结果。